During a Case-Based Roundtable® event, Sairah Ahmed, MD, discussed how the burgeoning use of chimeric antigen receptor T-cell ...

Rahul Banerjee, MD, FACP, physician-researcher at Fred Hutch Cancer Center in Seattle, WA, discusses the potential links ...

Jose Lutzky, MD, discusses the innovative tumor-inflitrating lymphocyte therapy for the treatment of relapsed or refractory melanoma.

In separate live virtual events, James K. McCloskey II, MD, and Bart L. Scott, MD, polled participants on disease symptoms and bridging therapy options for a patient with primary myelofibrosis (PMF).

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

In an interview with Targeted Oncology, Joe Leach, MD, highlighted the current state and future prospects of treating ...

During a Case-Based Roundtable® event, Sumanta K. Pal, MD, moderated a discussion on quality of life data and experiences ...

A correlation between non–small cell lung cancer (NSCLC) and influenza shows a decrease in cancer survival rates. In a study ...

While oncolytic viruses represent a novel and exciting approach to cancer treatment, there is a key challenge: resistance. According to Howard D. Edington, MD, resistance is a major obstacle seen in ...

RAG-01 has received an FDA fast track designation and is being investigated for the treatment of non-muscle invasive bladder ...

During a Case-Based Roundtable® event, Yasir Y. Elamin, MD, asked participants their perspectives on the use of targeted ...

Change Healthcare, owned by UnitedHealth Group, was targeted by cybercriminals, affecting 140 million Americans and costing $1 billion daily. Recovery efforts underscore the critical need for robust ...